ライフサイエンスコーパス: will hopefully

1 The use of mice will hopefully accelerate progress towards useful regene

2 l in predicting severity of illness but also will hopefully allow for identification of the disease p

3 sent a random sample from India, our results will hopefully assist in the design of future studies th

4 lating biomarkers or therapeutic modalities, will hopefully be able to provide a strong basis for fut

5 ng disease or genetic context are needed and will hopefully be addressed by future work in this field

6 ferent agents in synergistic strategies that will hopefully be successful in stopping the growth and

7 e investment in public health infrastructure will hopefully be sustained in the United States so that

8 s compilation of industry experience in FBDD will hopefully be useful for those pursuing FBDD in acad

9 o highlight recent, select developments that will hopefully benefit the new and seasoned scientist al

10 channel distribution should be possible and will hopefully bring safer and more-potent medicines in

11 ding of the pathophysiology of chronic pain, will hopefully bring the promise of new therapeutics tha

12 with chemotherapeutic regimens continues and will hopefully broaden our treatment strategy for patien

13 forms for the treatment of relapsed MCL, and will hopefully change the outcome for patients with this

14 Ultimately, these tracers will hopefully clarify the pathophysiological role of am

15 Future multidisciplinary curricular progress will hopefully continue to build upon this e-learning st

16 The emerging technologies will hopefully continue to promote this trend.

17 These findings will hopefully contribute to an exploration of the funct

18 e simplified CPR guidelines released in 2005 will hopefully contribute to improved bystander delivery

19 ly based harmonized definition of MHO, which will hopefully contribute to more comparable data in the

20 thophysiology of chronic itching conditions, will hopefully contribute to the development of new anti

21 Future research will hopefully define specific risk prediction tools and

22 Future studies will hopefully define the benefits and role of cancer su

23 New insights will hopefully emerge once the first detailed lipoprotei

24 e most extensively researched and strategies will hopefully emerge to increase its activity and provi

25 llenging, but neglected area of rheumatology will hopefully entice them to explore these conditions w

26 These formalized consensus descriptions will hopefully facilitate ongoing and future research ef

27 This document provides a framework that will hopefully facilitate the clearest communication bet

28 The proposed criteria will hopefully facilitate the development of novel appro

29 -cell lung cancer (NSCLC) is progressing and will hopefully follow in the same footsteps as that of b

30 pproaches to modulate inflammatory pathways, will hopefully further expand our ability to understand

31 use of new drugs such as brentuximab vedotin will hopefully further increase the cure rates.

32 mechanism leading to the DGS/VCFS phenotype will hopefully further our understanding of cardiac deve

33 cular markers built into many ongoing trials will hopefully generate more insights in the near future

34 els of PD, and in clinical trial methodology will hopefully hasten the resolution of these problems.

35 Consideration of these issues now will hopefully help foster an informed approach to the c

36 of data into the beginnings of a model that will hopefully help to guide research towards a full-sca

37 ogress in the understanding of DC physiology will hopefully help us create the necessary vaccines to

38 roader understanding of the biology of MF/SS will hopefully identify more effective targeted therapie

39 rget other pathways involved in angiogenesis will hopefully improve on the results of current anti-VE

40 for the assessment of practice patterns that will hopefully improve physician decision making.

41 reatment of relapsed and refractory NHL, and will hopefully improve the clinical outcome for these pa

42 Knowledge of the lipidic contribution will hopefully inspire development of novel synthetic bi

43 e attention of all relevant shareholders and will hopefully inspire future national and local guideli

44 s of climate change on migratory species and will hopefully inspire future work on rainfall and tropi

45 le for preclinical medicine, in general, and will hopefully instill greater confidence in the clinica

46 immune triggers of IBD in a genetic context will hopefully lead to a better understanding of the pat

47 pplying concepts learned in HIV therapeutics will hopefully lead to a prudent and cautious path in HC

48 nd endpoints leading to multicenter studies, will hopefully lead to advancements in the prevention of

49 ecretion, delivery and function of effectors will hopefully lead to alternative control measures, whi

50 This knowledge will hopefully lead to better diagnosis and treatment an

51 of lung development and regeneration, which will hopefully lead to better insights into both congeni

52 s in the context of other signaling pathways will hopefully lead to biology based therapeutic strateg

53 ects in various models over the coming years will hopefully lead to establishment of this receptor as

54 on of LQTS patients and their family members will hopefully lead to improved gene-specific prognostic

55 ogy into uniformly adopted response criteria will hopefully lead to improved outcome for patients wit

56 m that uses these techniques is proposed and will hopefully lead to improved patient management.

57 g of the determinants of disease progression will hopefully lead to improved utilization of existing

58 emiology and pathophysiology of this disease will hopefully lead to improvement in patient outcomes.

59 anding of the pathophysiology of the bladder will hopefully lead to more effective and tolerated trea

60 These advances will hopefully lead to more effective therapies for spec

61 These advances will hopefully lead to more effective therapies for spec

62 anding of afferent mechanisms in the bladder will hopefully lead to more effective treatments of lowe

63 dissection of these molecular pathways that will hopefully lead to novel therapeutic options.

64 biogenesis cause specific clinical syndromes will hopefully lead to novel therapeutic strategies for

65 ithelial goblet cell abnormalities in asthma will hopefully lead to novel therapies for mucin hyperse

66 Understanding its unique pathogenesis will hopefully lead to the development of better, more t

67 proved understanding of CMML pathophysiology will hopefully lead to the exploration of novel targets

68 er progression in inflammatory bowel disease will hopefully lead to the identification of useful prog

69 f interstitial cystitis is emerging and this will hopefully lead to the introduction of novel therapi

70 This review will hopefully look at the recent evidence in the field

71 eptor tyrosine kinase FLT3, and its approval will hopefully mark the beginning of an era of targeted

72 lication of more advanced signal processing, will hopefully open new avenues of research leading to t

73 Characterizing this network will hopefully open the way to therapeutic approaches th

74 These advances will hopefully pave the way for improving both the proph

75 garette smoke can damage airway function and will hopefully pave the way for the development of ratio

76 This will hopefully permit a better future for patients with

77 physics literature as "phenomenology"; they will, hopefully, play a significant role in future studi

78 ase course or in combination with each other will hopefully produce more durable responses with less

79 t population is exciting and much needed and will hopefully prompt further investigation into additio

80 in concert with other transcription factors will hopefully provide a better mechanistic understandin

81 This model will hopefully provide a useful framework for studying m

82 individual, the genetically modified T cells will hopefully provide durable killing of infected cells

83 Ongoing risk-adapted studies will hopefully provide evidence for clinical improvement

84 ated mechanosensation and signaling activity will hopefully provide important insights into the mecha

85 s the best validated of the new markers, and will hopefully provide insight into how to use this biom

86 abilisation of tumour volume with everolimus will hopefully provide long-term clinical benefit in pat

87 An integrative view of the different levels will hopefully provide much needed insight into understa

88 egarding epigenetic control mechanisms which will hopefully provide new advances in diagnostics and p

89 The accumulating data from these studies will hopefully provide new ideas for combating autoimmun

90 into the mechanism involved in this response will hopefully provide new insight into the pathogenesis

91 of melanocyte contributions to skin biology will hopefully provide new opportunities for the prevent

92 Thus, BiTE((R)) antibody constructs will hopefully provide new treatment options for patient

93 Ongoing high-throughput genetic projects will hopefully provide novel insight into the biological

94 These data will hopefully provide the impetus for development of no

95 This will hopefully provide the necessary impetus to change t

96 h bevacizumab and paclitaxel, is planned and will hopefully provide us with new directions on how to

97 lerosis is not only clinically relevant, but will hopefully provide valuable insights into the mediat

98 elevant targets in neoplastic mast cells and will hopefully receive recognition by health authorities

99 to develop novel therapeutic strategies that will hopefully result in better treatment outcomes.

100 opism of liver metastasis from breast cancer will hopefully result in improved targeted therapies to

101 rocesses underlying kidney injury and repair will hopefully result in the design of more targeted the

102 ration in the pharmaceutical industry, which will hopefully result in the development of improved bon

103 tero continue to improve, future generations will hopefully see a reduction in both prenatal and neon

104 mmes in non-model organisms, the next decade will hopefully see these phylogenetic findings integrate

105 The technique will hopefully serve as a guide for the further analysis

106 and controversies and ongoing trials, which will hopefully shed light in these areas.

107 standardized and the next stages of research will hopefully shed light on how to maximize the efficac

108 acids with the capacity for phloem transport will hopefully shed new light on the regulation of phloe

109 applications of leptin continue to grow and will hopefully soon be used therapeutically.

110 cancer immunosurveillance and immunoediting will hopefully stimulate development of more effective i

111 risk into clinical trials using novel agents will hopefully streamline head and neck cancer chemoprev

112 epithelial immune and inflammatory responses will hopefully suggest new strategies for therapeutic in

113 These new technologies will hopefully support the use of GEMs in preclinical tr

114 nderstanding of PTEN function and regulation will hopefully translate into improved prognosis and tre

115 variety of infection and inflammation models will hopefully translate to new therapies.

116 tionary adaptations to become predatory, and will hopefully ultimately illuminate how the predatory p

117 udies should yield important new data, which will hopefully ultimately result in improved outcomes.

118 This review will hopefully will provide useful material for future s